GSK Pharma Apr-Jun qtr profit seen at Rs 126.6 cr: Religare
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, GSK Pharma's June quarter sales are expected to go up by 9.8% to Rs 457.8 crore on YoY basis.
Like this story, share it with millions of investors on M3
GSK Pharma Apr-Jun qtr profit seen at Rs 126.6 cr: Religare
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, GSK Pharma's June quarter sales are expected to go up by 9.8% to Rs 457.8 crore on YoY basis.
Like this story, share it with millions of investors on M3
GSK Pharma Apr-Jun qtr profit seen at Rs 126.6 cr: Religare
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, GSK Pharma's June quarter sales are expected to go up by 9.8% to Rs 457.8 crore on YoY basis.
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, GSK Pharma 's June quarter sales are expected to go up by 9.8% to Rs 457.8 crore on YoY basis.
The company's net profit is expected to go up by 10.2% to Rs 126.6 crore on YoY basis.
